Cargando…

Experiences from six years of quality assured Model of End Stage Liver Disease (MELD) diagnostics

BACKGROUND: The model of end-stage liver disease (MELD) score was established for the allocation of liver transplants. The score is based on the medical laboratory parameters: bilirubin, creatinine and the international normalized ratio (INR). A verification algorithm for the laboratory MELD diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hunold, Pascal, Berg, Thomas, Seehofer, Daniel, Sucher, Robert, Herber, Adam, Isermann, Berend, Thiery, Joachim, Kaiser, Thorsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389365/ https://www.ncbi.nlm.nih.gov/pubmed/34437537 http://dx.doi.org/10.1371/journal.pone.0254219

Ejemplares similares

Raman spectroscopy on blood serum samples of patients with end-stage liver disease
por: Staritzbichler, René, et al.
Publicado: (2021)

Low PCSK9 levels are correlated with mortality in patients with end-stage liver disease
por: Schlegel, Valentin, et al.
Publicado: (2017)

Revising the MELD Score to Address Sex-Bias in Liver Transplant Prioritization for a German Cohort
por: Walter Costa, Maria Beatriz, et al.
Publicado: (2023)

The Usefulness of Mayo End-stage Liver Disease (MELD) and MELD-Sodium (MELD-Na) Scores for Predicting Mortality in Cirrhotic Patients With Spontaneous Bacterial Peritonitis
por: Coxeter-Smith, Catherine, et al.
Publicado: (2023)

Limited comparability of creatinine assays in patients with liver cirrhosis and their impact on the MELD score
por: Kaiser, Thorsten, et al.
Publicado: (2017)

Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine
por: Lau, Tsang, et al.
Publicado: (2013)

Correlation of Model for End Stage Liver Disease (MELD), MELD-Sodium (MELD-Na), and Child-Turcotte-Pugh (CTP) Score With Frailty in Patients With Hepatitis C Virus (HCV) Related Cirrhosis
por: Panezai, Muhammad Qaiser, et al.
Publicado: (2023)

THE USE OF MELD SCORE (MODEL FOR END-STAGE LIVER DISEASE) AND DERIVATIVES IN CARDIAC TRANSPLANTATION
por: de MORAES, Ana Claudia Oliveira, et al.
Publicado: (2018)

Plasma Amino Acid Concentrations Predict Mortality in Patients with End-Stage Liver Disease
por: Kinny-Köster, Benedict, et al.
Publicado: (2016)

Validation of the Model for End‐stage Liver Disease sodium (MELD‐Na) score in the Eurotransplant region
por: Goudsmit, Ben F. J., et al.
Publicado: (2020)

MELD-GRAIL and MELD-GRAIL-Na Are Not Superior to MELD or MELD-Na in Predicting Liver Transplant Waiting List Mortality at a Single-center Level
por: Chetwood, John D., et al.
Publicado: (2022)

Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis
por: Sheth, Milan, et al.
Publicado: (2002)

The Potential Role of Model for End-Stage Liver Disease (MELD)-Sodium Score in Predicting the Severity of Acute Pancreatitis
por: Nayci, Ali Emre, et al.
Publicado: (2022)

Biomarkers for Non-Invasive Stratification of Coronary Artery Disease and Prognostic Impact on Long-Term Survival in Patients with Stable Coronary Heart Disease
por: Netto, Jeffrey, et al.
Publicado: (2022)

Detecting Pre-Analytically Delayed Blood Samples for Laboratory Diagnostics Using Raman Spectroscopy
por: Hunold, Pascal, et al.
Publicado: (2023)

Low sphingosine-1-phosphate plasma levels are predictive for increased mortality in patients with liver cirrhosis
por: Becker, Susen, et al.
Publicado: (2017)

Cholesterol esterification in plasma as a biomarker for liver function and prediction of mortality
por: Kaiser, Thorsten, et al.
Publicado: (2017)

Inclusion of Sarcopenia Within MELD (MELD-Sarcopenia) and the Prediction of Mortality in Patients With Cirrhosis
por: Montano-Loza, Aldo J, et al.
Publicado: (2015)

Prognostic value of the modified model for end-stage liver disease (MELD) score including albumin in acute heart failure
por: Liao, Shengen, et al.
Publicado: (2021)

ASO Author Reflections: Hepatobiliary Surgeons are Spurred to Implement Totally Minimally Invasive Techniques for Perihilar Cholangiocarcinoma Surgery
por: Sucher, Robert, et al.
Publicado: (2020)

Use of rapid Model for End-Stage Liver Disease (MELD) increases for liver transplant registrant prioritization after MELD-Na and Share 35, an evaluation using data from the United Network for Organ Sharing
por: Brock, Guy N., et al.
Publicado: (2019)

Liver Transplantation in Patients with Portal Vein Thrombosis: Comparing Pre-MELD and MELD era
por: Saidi, R. F., et al.
Publicado: (2012)

Prognostic Value of Hepatorenal Function By Modified Model for End‐stage Liver Disease (MELD) Score in Patients Undergoing Tricuspid Annuloplasty
por: Chen, Yan, et al.
Publicado: (2018)

Relationship between right atrial pressure and the Model for End-Stage Liver Disease (MELD) score in patients with advanced heart failure
por: Acar, Rezzan Deniz, et al.
Publicado: (2022)

Model for End Stage Liver Disease (MELD) Score: A Tool for Prognosis and Prediction of Mortality in Patients With Decompensated Liver Cirrhosis
por: Emenena, Isioma, et al.
Publicado: (2023)

Hyperspectral Evaluation of the Human Liver During Major Resection
por: Sucher, Elisabeth, et al.
Publicado: (2022)

Invited response to “MELD calibration”
por: Goudsmit, Ben F. J., et al.
Publicado: (2020)

MELD-GRAIL-Na Is a Better Predictor of Mortality Than MELD in Korean Patients with Cirrhosis
por: Kim, Jung-Woo, et al.
Publicado: (2023)

Future Systems of Xenotransplantation: Melding Historical and Bioethical Methodology
por: Negri, Adam, et al.
Publicado: (2023)

Model for End-stage Liver Disease excluding INR (MELD-XI) score in critically ill patients: Easily available and of prognostic relevance
por: Wernly, Bernhard, et al.
Publicado: (2017)

Prognostic value of the model for end-stage liver disease excluding INR score (MELD-XI) in patients with adult congenital heart disease
por: Konno, Ryo, et al.
Publicado: (2019)

Development and Validation of a Novel Tool to Predict Model for End-Stage Liver Disease (MELD) Scores in Cirrhosis, Using Administrative Datasets
por: Simon, Tracey G, et al.
Publicado: (2023)

MELD-Sarcopenia is Better than ALBI and MELD Score in Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation
por: Alsebaey, Ayman, et al.
Publicado: (2021)

MELD or MELD-Na as a Predictive Model for Mortality Following Transjugular Intrahepatic Portosystemic Shunt Placement
por: Krishnan, Arunkumar, et al.
Publicado: (2023)

Total Laparoscopic Resection of Hilar Cholangiocarcinoma Type 3b: Applying a Parachute Technique for Hepaticojejunostomy
por: Sucher, Robert, et al.
Publicado: (2020)

MELD, MELD 3.0, versus Child score to predict mortality after acute variceal hemorrhage: A multicenter US cohort
por: Buckholz, Adam, et al.
Publicado: (2023)

MELD: Mixed effects for large datasets
por: Nielson, Dylan M., et al.
Publicado: (2017)

The Melding of Drug Screening Platforms for Melanoma
por: Couto, Gabriela Klein, et al.
Publicado: (2019)

Model of end stage liver disease (MELD) score greater than 23 predicts length of stay in the ICU but not mortality in liver transplant recipients
por: Oberkofler, Christian E, et al.
Publicado: (2010)

A Novel Use of Model for End-Stage Liver Disease (MELD) Score in Guiding Therapeutic Antibiotics Choice for Critically Ill Cirrhotic Patients
por: Zhou, Yi-Fan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_73c0m3t6jsfc9vte7unogvap0v